1月15日晚，洛阳钼业发布公告，预计2025年度实现归属于公司股东的净利润为人民币200亿元到人民币 208亿元，与上年同期相比，将增加人民币64.68亿元到人民币72.68亿元，同比增加47.80%到53.71%。 热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易 客户端 洛阳钼业（03993）早盘股价上涨4.55%，现报23.42港元，成交额6.12亿港元。 热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易 客户端 预计2025年度实现归属于公司股东的扣除非经常性损益的净利润为人民币204亿元到人民币212亿元，与 上年同期相比，将增加人民币72.81亿元到人民币80.81亿元，同比增加55.50%到61.60%。 责任编辑：卢昱君 洛阳钼业（03993）早盘股价上涨4.55%，现报23.42港元，成交额6.12亿港元。 1月15日晚，洛阳钼业发布公告，预计2025年度实现归属于公司股东的净利润为人民币200亿元到人民币 208亿元，与上年同期相比，将增加人民币64.68亿元到人民币72.68亿元，同比增加47.80%到53.71%。 预计2025年度实现归属于公司股东的扣除非经常性损益的 ...

摩根士丹利发表报告指，洛阳钼业发盈喜，预计2025年净利润为200亿至208亿元，按年增长48%至 54%，符合市场预期的202亿元。单计去年第四季净利润介乎57至65亿元，按季升2%至16%。管理层表 示，业绩理想主要受惠于产量及价格同步上升，加上成本控制得宜。公司计划2026年铜产量为76万至82 万吨，按中位数计算按年增长7%；并计划每年来自新收购巴西金矿的黄金产量为6吨至8吨，目标今年 第一季完成收购。该行现予洛阳钼业H股目标价23.2港元，洛阳钼业A股目标价22.5元，均予"增持"评 级。 ...

消息面上，1月15日晚，洛阳钼业发布公告，预计2025年度实现归属于公司股东的净利润为人民币200亿 元到人民币208亿元，与上年同期相比，将增加人民币64.68亿元到人民币72.68亿元，同比增加47.80% 到53.71%。 预计2025年度实现归属于公司股东的扣除非经常性损益的净利润为人民币204亿元到人民币212亿元，与 上年同期相比，将增加人民币72.81亿元到人民币80.81亿元，同比增加55.50%到61.60%。 洛阳钼业（603993）(03993)涨超3%，截至发稿，涨3.48%，报23.12港元，成交额3.76亿港元。 ...

预计2025年度实现归属于公司股东的扣除非经常性损益的净利润为人民币204亿元到人民币212亿元，与 上年同期相比，将增加人民币72.81亿元到人民币80.81亿元，同比增加55.50%到61.60%。 消息面上，1月15日晚，洛阳钼业发布公告，预计2025年度实现归属于公司股东的净利润为人民币200亿 元到人民币208亿元，与上年同期相比，将增加人民币64.68亿元到人民币72.68亿元，同比增加47.80% 到53.71%。 智通财经APP获悉，洛阳钼业(03993)涨超3%，截至发稿，涨3.48%，报23.12港元，成交额3.76亿港元。 ...

公司发布的三季报数据显示，前三季度公司共实现营业收入1454.85亿元，同比下降5.99%，实现净利润 142.80亿元，同比增长72.61%，基本每股收益为0.6700元，加权平均净资产收益率18.65%。 1月16日公司发布2025年业绩预告，预计实现净利润200.00亿元至208.00亿元，同比变动区间为 47.80%~53.71%。（数据宝） （文章来源：证券时报网） 洛阳钼业股价再创历史新高，该股近期呈不断突破新高之势，近一个月累计有13个交易日股价刷新历史 纪录。截至09:36，该股目前上涨2.37%，股价报24.62元，成交4487.31万股，成交金额10.95亿元，换手 率0.26%，该股最新A股总市值达4298.86亿元，该股A股流通市值4298.86亿元。 证券时报·数据宝统计显示，洛阳钼业所属的有色金属行业，目前整体涨幅为1.91%，行业内，目前股价 上涨的有120只，涨幅居前的有湖南白银、天力复合、锌业股份等，涨幅分别为8.16%、8.10%、 7.25%。股价下跌的有18只，跌幅居前的有华锡有色、丽岛新材、江南新材等，跌幅分别为1.38%、 1.21%、0.99%。 两融数据显示，该 ...

Core Viewpoint - Luoyang Molybdenum Co., Ltd. shows strong trading activity with significant financing and margin trading, indicating investor interest despite a slight decline in revenue year-on-year [1][2]. Financing Activity - On January 15, Luoyang Molybdenum's stock rose by 3.22% with a trading volume of 7.304 billion yuan - The financing buy-in amount for the day was 644 million yuan, while financing repayment was 588 million yuan, resulting in a net financing buy of 55.69 million yuan - As of January 15, the total financing and margin trading balance reached 4.155 billion yuan, with the financing balance at 4.123 billion yuan, accounting for 0.98% of the circulating market value, which is above the 90th percentile of the past year [1]. Margin Trading - On January 15, Luoyang Molybdenum had a margin repayment of 44,400 shares and a margin sell of 106,400 shares, with a selling amount of approximately 2.5589 million yuan based on the closing price - The remaining margin balance was 1.3074 million shares, with a margin balance of 31.443 million yuan, also exceeding the 90th percentile of the past year [1]. Company Overview - Luoyang Molybdenum, established on December 22, 1999, and listed on October 9, 2012, is primarily engaged in the mining, selection, deep processing, trading, and research of rare metals such as molybdenum, tungsten, and gold [2]. - The company's revenue composition includes refined metal product trading (48.56%), concentrate product trading (38.31%), copper (27.14%), cobalt (6.04%), molybdenum (3.12%), phosphorus (2.23%), niobium (1.88%), tungsten (1.17%), and others (0.11%) [2]. Financial Performance - For the period from January to September 2025, Luoyang Molybdenum reported a revenue of 145.485 billion yuan, a year-on-year decrease of 5.99% - The net profit attributable to shareholders was 14.280 billion yuan, reflecting a year-on-year increase of 72.61% [2]. Dividend Distribution - Since its A-share listing, Luoyang Molybdenum has distributed a total of 21.562 billion yuan in dividends, with 10.576 billion yuan distributed over the past three years [3]. Institutional Holdings - As of September 30, 2025, the top ten circulating shareholders include Hong Kong Central Clearing Limited as the fourth largest shareholder with 669.5 million shares, an increase of 47.472 million shares from the previous period - Other notable shareholders include Huaxia SSE 50 ETF and Huatai-PB CSI 300 ETF, with varying changes in their holdings [3].

热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易 客户端 洛阳钼业（03993）发布公告，预计2025年度实现归属于公司股东的净利润为人民币200亿元到人民币 208亿元，与上年同期相比，将增加人民币64.68亿元到人民币72.68亿元，同比增加47.80%到53.71%。 预计2025年度实现归属于公司股东的扣除非经常性损益的净利润为人民币204亿元到人民币212亿元，与 上年同期相比，将增加人民币72.81亿元到人民币80.81亿元，同比增加55.50%到61.60%。 公司2025年度业绩同比大幅上升的原因系公司主要产品销量及价格双双上升，叠加营运成本有效控制。 热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易 客户端 洛阳钼业（03993）发布公告，预计2025年度实现归属于公司股东的净利润为人民币200亿元到人民币 208亿元，与上年同期相比，将增加人民币64.68亿元到人民币72.68亿元，同比增加47.80%到53.71%。 预计2025年度实现归属于公司股东的扣除非经常性损益的净利润为人民币204亿元到人民币212亿元，与 上年同期相比，将增加人民币72.81亿元到人民币80. ...

1月15日晚间，洛阳栾川钼业集团股份有限公司(以下简称"洛阳钼业（603993）")发布业绩预报，预计 2025年实现归属于上市公司股东的净利润为200亿元至208亿元，同比增长47.8%至53.71%；扣非净利润 为204亿元至212亿元，同比增长55.5%至61.6%。 2025年，洛阳钼业提出"多品种、多国家、多阶段"，聚焦"铜+黄金"两极的并购战略，在黄金资源布局 上连续取得重大突破。2025年6月份，该公司完成厄瓜多尔奥丁矿业的收购，该项目正在前期规划中； 12月份，洛阳钼业又宣布以10.15亿美元并购巴西3个黄金资产，预计2026年第一季度完成交割。因此公 司首次将黄金纳入产品序列，明确全年6吨至8吨黄金的产量目标。 洛阳钼业相关负责人表示，2026年，洛阳钼业将围绕"铜+黄金"战略，继续挖掘现有矿山潜力，用精细 化运营提效管理，并继续择机进行全球资源布局。 结合全球经济研判、供求关系变化，洛阳钼业2026年产量指引为：产铜金属76万吨至82万吨；钴金属10 万吨至12万吨；黄金6吨至8吨。如达到指引上限，2026年洛阳钼业将提前实现产铜80万吨目标。 据透露，洛阳钼业目前正积极推进位于刚果(金) ...

Major Events - Giant Bio (02367) received the Medical Device Registration Certificate from the National Medical Products Administration for its recombinant type I α1 collagen and sodium hyaluronate composite solution [1] - Jitu Express-W (01519) plans to subscribe for 226 million H shares of SF Holding and issue 822 million Class B shares to SF Holding [1] - Zijin Mining (02899) signed a cooperation and equity transfer agreement for the Shapingou Molybdenum Mine project [1] - Jiangxi Copper (00358) subsidiary signed an Investment Option Agreement with First Quantum for exploration cooperation in Kazakhstan's mining projects [1] - Derin Holdings (01709) received conditional approval from the CSRC for Derin Securities to provide virtual asset consulting services [1] - GAC Group (02238) subsidiary GAC Trumpchi received 100 million yuan in funding for industrial transformation and development [1] - Juteng International (03336) suspected of a cyber attack and has initiated a comprehensive investigation [1] Operating Performance - China Southern Airlines (01055) increased passenger capacity input by 11.89% year-on-year in December [1] - Air China (00753) reported a 10% year-on-year increase in passenger turnover in December [1] - China Eastern Airlines (00670) saw a 7.61% year-on-year increase in passenger turnover in December [1] - China Metallurgical Group (01618) new contract amount for 2025 is 1,113.6 billion yuan, a decrease of 10.8% year-on-year [1] - ZhongAn Online (06060) projected total original insurance premium income of approximately 35.643 billion yuan for 2025, an increase of 6.66% year-on-year [1] - China General Nuclear Power Corporation (01164) produced a total of 702.5 tons of natural uranium in the fourth quarter [1] - Jiuxing Holdings (01836) reported a 0.8% year-on-year increase in comprehensive income to 388.6 million USD in the fourth quarter [1] - Luoyang Molybdenum (03993) issued a profit warning, expecting annual net profit attributable to shareholders to be between 20 billion and 20.8 billion yuan, an increase of 47.80% to 53.71% year-on-year [1] - Chongqing Iron and Steel (01053) issued a profit warning, expecting a net loss of 2.5 billion to 2.8 billion yuan for 2025 [1] - Huiju Technology (01729) issued a profit warning, expecting annual net profit to increase by approximately 60% to 70% year-on-year [1]

Core Viewpoint - Luoyang Molybdenum Co., Ltd. plans to use no more than 20 billion RMB of its idle funds for wealth management and entrusted wealth management products, pending shareholder approval [1][4]. Group 1: Investment Plan - The company and its wholly-owned and controlling subsidiaries intend to invest in high-security, liquid wealth management or entrusted wealth management products, excluding structured deposits [4]. - The total investment balance for these products shall not exceed 20 billion RMB (or equivalent foreign currency), with the investment period effective from the date of approval at the 2025 annual general meeting until the 2026 annual general meeting [4]. - The board of directors approved this proposal on January 15, 2026, and it will be submitted for shareholder approval [4]. Group 2: Risk and Returns - The wealth management and entrusted wealth management products are considered to have controllable risks, although the returns may experience slight fluctuations that could impact the company's overall wealth management income [4].